Population pharmacokinetic model for a novel recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in hemophilia B patients

被引：0
|
作者：
Parasrampuria, R. [1 ]
Easton, R. [1 ]
Yao, Z. [1 ]
Bensen-Kennedy, D. [1 ]
Voigt, C. [1 ]
Jacobs, I [1 ]
Massimo, M. [2 ]
机构：
[1] CSL Behring, King Of Prussia, PA USA
[2] Azienda Osped Univ Careggi, Florence, Italy
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2013年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：829 / 829
页数：1
相关论文
共 50 条
  • [21] Results of a phase I international clinical trial of recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in patients with hemophilia B (PROLONG-9FP)
    Santagostino, E.
    Negrier, C.
    Klamroth, R.
    Tiede, A.
    Pabinger, I.
    Trossaert, M.
    Martinowitz, U.
    Altisent, C.
    Tagliaferri, A.
    Rothschild, C.
    Roman, M. A.
    Lopez-Fernandez, M. F.
    Castaman, G.
    Lambert, T.
    Von Depka-Prondzinski, M.
    Voigt, C.
    Jacobs, I.
    Morfini, M.
    HAEMOPHILIA, 2012, 18 : 22 - 22
  • [22] SAFETY AND EFFICACY OF RECOMBINANT FACTOR IX FUSION PROTEIN (RIX-FP) IN PUPS WITH HEMOPHILIA B
    Lemons, Richard
    Wang, Michael
    Curtin, Julie
    Lepatan, Lynda Mae
    Male, Christoph
    Peyvandi, Flora
    Von Depka, Mario
    PEDIATRIC BLOOD & CANCER, 2023, 70 : S174 - S175
  • [23] Efficacy and safety of long-acting recombinant fusion protein linking factor IX with albumin (rIX-FP) in hemophilia B patients undergoing surgery
    Karim, Faraizah Abdul
    Lepatan, Lynda Mae
    Lienhart, Anne-Marie
    Lopez Fernandez, Maria Fernanda
    Mahlangu, Johnny
    Pabinger, Ingrid
    Li, Yanyan
    Wolko, Denise
    Voigt, Christine
    Jacobs, Iris
    HAEMOPHILIA, 2016, 22 : 44 - 44
  • [24] Efficacy and Safety Results of Prolong-9FP Clinical Program of Recombinant Fusion Protein Linking Coagulation Factor IX with Albumin (rIX-FP) in Previously Treated Patients with Hemophilia B
    Santagostino, Elena
    Voigt, Christine
    Wolko, Denise
    Cole, Grace
    Li, Yanyan
    Jacobs, Iris C.
    BLOOD, 2015, 126 (23)
  • [25] ANALYSIS OF EXTENDED DOSING REGIMENS WITH RECOMBINANT COAGULATION FACTOR IX ALBUMIN FUSION PROTEIN (RIX-FP) IN ADULT AND PAEDIATRIC PATIENTS WITH HAEMOPHILIA B: A POPULATION PHARMACOKINETIC SIMULATION
    McKeand, W.
    Roberts, J.
    Yuraszeck, T.
    Goldstein, B.
    Tortorici, M. A.
    HAEMOPHILIA, 2021, 27 : 42 - 43
  • [26] Long-acting recombinant coagulation factor IX albumin fusion protein (rIX-FP) in hemophilia B: results of a phase 3 trial
    Santagostino, Elena
    Martinowitz, Uri
    Lissitchkov, Toshko
    Pan-Petesch, Brigitte
    Hanabusa, Hideji
    Oldenburg, Johannes
    Boggio, Lisa
    Negrier, Claude
    Pabinger, Ingrid
    Prondzinski, Mario von Depka
    Altisent, Carmen
    Castaman, Giancarlo
    Yamamoto, Koji
    Alvarez-Roman, Maria-Teresa
    Voigt, Christine
    Blackman, Nicole
    Jacobs, Iris
    BLOOD, 2016, 127 (14) : 1761 - 1769
  • [27] Safety and pharmacokinetic results of a phase I/II clinical trial of recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in previously treated patients with hemophilia B (PROLONG-9FP)
    Lubetsky, A.
    Lissitchkov, T.
    Yotov, G.
    Luboshitz, J.
    Lelazari, S.
    Barazani-Brutman, T.
    Santagostino, E.
    Voigt, C.
    Zanette, M.
    Jacobs, I.
    Martinowitz, U.
    HAEMOPHILIA, 2012, 18 : 24 - 24
  • [28] Efficacy and safety results of a phase 3 pivotal clinical study of recombinant fusion protein linking coagulation factor IX with albumin (RIX-FP) in previously treated patients with hemophilia B
    Santagostino, E.
    Martinowitz, U.
    Lissitchkov, T.
    Pan-Petesch, B.
    Hanabusa, H.
    Oldenburg, J.
    Boggio, L.
    Negrier, C.
    Pabinger-Fasching, I
    Prondzinski, von Depka M.
    Altisent, C.
    Castaman, G.
    Yamamoto, K.
    Alvarez-Roman, M.
    Voigt, C.
    Jacobs, I
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 228 - 228
  • [29] Pharmacokinetic Results of Two Phase III Clinical Studies of Coagulation Factor IX (Recombinant) Albumin Fusion Protein (rIX-FP) in Previously Treated Patients with Hemophilia B (PROLONG-9FP)
    Santagostino, Elena
    Jacobs, Iris C.
    Voigt, Christine
    Feussner, Annettee
    Limsakun, Tharin
    BLOOD, 2014, 124 (21)
  • [30] Long-Term Use of Coagulation Factor IX (Recombinant) Albumin Fusion Protein (rIX-FP) in Previously Treated Patients with Hemophilia B in the Prolong-9FP Program
    Lubetsky, Aaron
    Martinowitz, Uri
    Lissitchkov, Toshko
    Voigt, Christine
    Wolko, Denise
    Jacobs, Iris C.
    Santagostino, Elena
    BLOOD, 2015, 126 (23)
12345